Lasa Supergenerics Limited (NSE:LASA)
India · Delayed Price · Currency is INR 7.32
-0.21 (-2.79%)
Jul 13, 2026, 3:27 PM IST
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 366.74 million as of July 13, 2026. Its market cap has decreased by -25.61% in one year.
Market Cap
366.74M
Enterprise Value
457.25M
Revenue
253.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.32
Market Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 366.74M, a decrease of -89.62%. That is a compound annual growth rate of -22.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 366.74M | -22.46% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 15.63B |
| Sigachi Industries | 8.66B |
| Bafna Pharmaceuticals | 4.84B |
| Valiant Laboratories | 3.37B |
| Nectar Lifesciences | 2.17B |
| Brooks Laboratories | 2.07B |
| Alpa Laboratories | 1.44B |
| Balaxi Pharmaceuticals | 1.33B |